InsiderClue
Insiders · Profile

MOTT DAVID M

Director at ARDELYX · Director at Enliven Therapeutics · Director at NOVAVAX · and 5 more. Filing since 5 Jun 2015. CIK 0001219871

ARDX ARDELYX, INC. Director · 20 trades ELVN Enliven Therapeutics, Inc. Director · 9 trades NVAX NOVAVAX INC Director · 1 trade MIRM Mirum Pharmaceuticals, Inc. 10% owner · 1 trade TRVI Trevi Therapeutics, Inc. 10% owner · 1 trade ORKA Oruka Therapeutics, Inc. 10% owner · 1 trade APPN APPIAN CORP 10% owner · 2 trades RYTM RHYTHM PHARMACEUTICALS, INC. 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
ARDX ARDELYX, INC.
20 Feb 2026
Director
Bought
333,333
$1.95M
11.2%
ARDX ARDELYX, INC.
16 Jun 2025
Director
Bought
200,000
$725.88K
7.4%
ARDX ARDELYX, INC.
9 Jun 2025
Director
Bought
200,000
$737.26K
8.0%
ARDX ARDELYX, INC.
15 May 2025
Director
Bought
100,000
$329.12K
4.2%
ARDX ARDELYX, INC.
2 May 2025
Director
Bought
381,377
$1.61M
18.9%
ARDX ARDELYX, INC.
24 Feb 2025
Director
Bought
77,729
$388.74K
4.0%
ARDX ARDELYX, INC.
21 Jan 2025
Director
Bought
199,000
$992.67K
11.4%
ARDX ARDELYX, INC.
19 Dec 2024
Director
Bought
213,300
$996.58K
15.0%
ARDX ARDELYX, INC.
13 Nov 2024
Director
Bought
215,868
$996.60K
17.8%
ARDX ARDELYX, INC.
17 Nov 2022
Director
Bought
567,000
$1.00M
94.5%
ELVN Enliven Therapeutics, Inc.
23 Feb 2022
Director
Bought
35,257
$51.48K
18.2%
ELVN Enliven Therapeutics, Inc.
22 Feb 2022
Director
Bought
65,817
$102.67K
51.4%
ELVN Enliven Therapeutics, Inc.
18 Feb 2022
Director
Bought
50,398
$65.52K
64.8%
ELVN Enliven Therapeutics, Inc.
17 Feb 2022
Director
Bought
14,595
$17.08K
23.1%
ELVN Enliven Therapeutics, Inc.
16 Feb 2022
Director
Bought
11,779
$14.13K
22.9%
ELVN Enliven Therapeutics, Inc.
15 Feb 2022
Director
Bought
19,552
$23.46K
61.4%
ELVN Enliven Therapeutics, Inc.
14 Feb 2022
Director
Bought
8,500
$10.03K
36.4%
ELVN Enliven Therapeutics, Inc.
11 Feb 2022
Director
Bought
14,573
$17.92K
166%
ELVN Enliven Therapeutics, Inc.
10 Feb 2022
Director
Bought
8,753
$11.29K
opened
NVAX NOVAVAX INC
23 Sep 2021
Director
Sold, plan not stated
24,961
$6.31M
38.4%
ARDX ARDELYX, INC.
10 Dec 2020
Director
Bought
170,000
$1.00M
68.7%
ARDX ARDELYX, INC.
25 Jun 2020
Director
Bought
68,373
$476.04K
38.2%
ARDX ARDELYX, INC.
24 Jun 2020
Director
Bought
72,598
$489.86K
68.3%
ARDX ARDELYX, INC.
22 Jun 2020
Director
Bought
4,673
$31.52K
4.6%
MIRM Mirum Pharmaceuticals, Inc.
22 Jul 2019
10% owner
Bought
450,000
$6.75M
12.0%
TRVI Trevi Therapeutics, Inc.
9 May 2019
10% owner
Bought
2,500,000
$25.00M
129%
ORKA Oruka Therapeutics, Inc.
26 Feb 2018
10% owner
Sold, plan not stated
1,460,209
$731.27K
100%
APPN APPIAN CORP
27 Nov 2017
10% owner
Sold, plan not stated
569,620
$11.10M
100%
APPN APPIAN CORP
20 Nov 2017
10% owner
Sold, plan not stated
2,820,516
$54.97M
100%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
10% owner
Bought
550,000
$9.35M
12.6%
ARDX ARDELYX, INC.
18 Jul 2016
Director
Bought
763,651
$6.67M
40.2%
ARDX ARDELYX, INC.
18 Jul 2016
Director
Bought
763,650
$6.67M
40.2%
ARDX ARDELYX, INC.
13 Jan 2016
Director
Bought
500,000
$5.00M
35.7%
ARDX ARDELYX, INC.
13 Jan 2016
Director
Bought
500,000
$5.00M
35.7%
ARDX ARDELYX, INC.
5 Jun 2015
Director
Bought
1,401,869
$15.00M
opened
ARDX ARDELYX, INC.
5 Jun 2015
Director
Bought
1,401,869
$15.00M
opened
36 decisions on file.